medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2009, Number 1

<< Back Next >>

Rev Mex Pediatr 2009; 76 (1)

Nephrotic syndrome: clinical and histopathological features in 58 children

Urdaneta-Carruyo E, Guilarte-Gallardo LM, Angulo-Bravo LV, Urdaneta-Contreras AV
Full text How to cite this article

Language: Spanish
References: 18
Page: 5-8
PDF size: 115.61 Kb.


Key words:

Primary nephrotic syndrome, minimal injury, renal biopsy, steroids.

ABSTRACT

Objective. To study the epidemiological, clinical and histopathological features of children with nephrotic syndrome (NS) and its response to the treatment.
Material and methods. 58 patients treated in the hospital in five years were study.
Results. 31 patients were male (53%), the gender ratio was 1:1 and the age from 1 and 14 years. The higher frequency (38%) was observed in the group of 2-6 years. All showed edema, hypoalbuminemia, hyperlipidemia, hypercholesterolemia and massive proteinuria. 25 children (43%) had hematuria, and its permanence was related to resistance to the treatment. Initially, 19 patients (33%) had hypertension. Thirty six (63%) maintained normal values of urea and creatinine and in 28 of them (48%), the C3 fraction also was normal. Nine patients (16%), renal biopsy was made to them, being observed minimal injuries, such as more frequent histopathological finding. The majority (67%) had good response to steroids.
Conclusions. The NS is the disease with the higher morbidity among the renal diseases in children in our hospital and it is the fourth reason for consultation. In children it usually has good prognosis, but in some cases with resistant to steroids, it is necessary to assess renal function periodically and to do renal biopsy at the same time, following various therapeutic strategies.


REFERENCES

  1. Barrat TM, Clark G. Minimal change nephrotic syndrome and focal glomerulosclerosis. In: Holliday AM, Barrat TM, Avner DE, editors. Pediatric nephrology. 3rd ed. Baltimore: Williams and Wilkins, 1994: 767-877.

  2. International Study of Kidney Diseases in Children. Nephrotic syndrome in children: Prediction of histopathology from clinic and laboratory characteristics and the time of diagnosis. Kidney Int 1978; 13: 159-65.

  3. Schlesinger ER, Sultz HA, Mosher WE, Feldman JC. The nephrotic syndrome. Its incidence and implications for the community. Am J Child Dis 1968; 116: 623-632.

  4. Garín EH. Síndrome nefrótico por nefropatía de lesiones mínimas. En: García NV, Santos F, Rodríguez B. Nefrología pediátrica. 2da ed. Madrid: Grupo Aula Médica, S.L. 2006: 303-12.

  5. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003; 23: 629-39.

  6. Academia Mexicana de Pediatría. Comité de Expertos en Nefrología. Síndrome nefrótico en niños. Bol Med Hosp Infant Mex 2000; 57: 522-536.

  7. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981; 98: 561-4.

  8. Report of the Second Task Force on Blood Pressure Control in Children. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987; 79(1): 1-25.

  9. International Study of Kidney Disease in Children. Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 1974; 2: 423.

  10. Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med 1998; 338: 1202-11.

  11. Seshan S. Glomerular diseases: A practical clinic-pathological approach for interpretation. New York: Weill Medical College, Cornell University. 2003: 3-14.

  12. Guignard JP, Santos F. Laboratory investigations. In: Avner ED, Harmon WE, Niaudet P, (eds). Pediatric nephrology. Philadelphia: Lippincott Williams & Wilkins, 2004: 399-424.

  13. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P et al. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 2003; 41: 550-7.

  14. Hodson EM, Knight JF, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children (Cochrane review). Cochrane Database Syst Rev 2003; 1: CD001533.

  15. Hodson EM, Craig JC, Willis NS. Evidence-based management of steroid sensitive nephrotic syndrome. Pediatr Nephrol 2005; 20: 1523-30.

  16. Saxena KM, Crawfor JD. The treatment of nephrosis. N Engl J Med 1989; 272: 522-6.

  17. Niaudet P. Steroid-sensitive idiopathic nephrotic syndrome in children. In: Avner ED, Harmon WE, Niaudet P, (eds). Pediatric nephrology. Philadelphia: Lippincott Williams & Wilkins, 2004: 543-56.

  18. Hogg RJ, Potman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J. Evaluation and management of proteinuria and nephrotic syndrome in children: Recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 2000; 105: 1242-9.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2009;76